Fungal Infection Identified by Pathogen Detection Array Technology
By LabMedica International staff writers Posted on 09 Feb 2016 |
Image: Sporangiophores, columellae and primitive rhizoids of Rhizomucor spp., the zygomycetous fungus detected by the PathoChip, which has the ability to detect all known viruses, as well as a variety of bacteria, fungi, helminths, and protozoa (Photo courtesy of the University of Adelaide).
Image: Rhizomucor pusillus (Photo courtesy of the University of Adelaide).
Patients who are undergoing treatment for diseases such as cancer often face the added challenge of a compromised immune system, which can be challenging to both of their condition and the drugs used to treat it, leaving them vulnerable to various opportunistic infections.
A novel investigational technology has been developed that can rapidly identify elusive microorganisms which are not only life-threatening, but those caused by rare organisms are extremely difficult to isolate and identify.
Scientists at the University of Pennsylvania (Philadelphia, PA, USA) utilized a pathogen array technology referred to as PathoChip, comprised of oligonucleotide probes that can detect all the sequenced viruses as well as known pathogenic bacteria, fungi and parasites and family-specific conserved probes, thus providing a means for detecting previously uncharacterized members of a family. The technology contains 60,000 probes that simultaneously test for all known viruses, as well as a variety of bacteria, fungi, helminths, and protozoa.
The investigators applied the PathoChip test to tissue samples of a patient with relapsed acute myelogenous leukemia (AML). The patient, a middle-aged man, had undergone chemotherapy for the cancer, a treatment that is well known to weaken the immune system, increasing susceptibility to infection. As a result, he developed an unknown fungal infection. The team rapidly identified a zygomycetous fungus, Rhizomucor, an otherwise challenge for the clinical laboratories, predominantly in the patient with acute myelogenous leukemia.
Erle Robertson, PhD, a professor and vice-chair for research in Otorhinolaryngology, said, “We've run many tests to see if we could identify pathogens in the laboratory, just to see if the PathoChip has efficacy in identifying a variety of organisms, and we were able to identify all infectious agents tested, but this was the first time we actually looked directly at a patient sample to identify a pathogenic agent. With this technology, out of 60,000 possibilities and probes that we used, in a little over 24 hours we were able to identify this particular fungi.” The study was published originally online on November 20, 2015, in the journal Cancer, Biology & Therapy.
Related Links:
University of Pennsylvania
A novel investigational technology has been developed that can rapidly identify elusive microorganisms which are not only life-threatening, but those caused by rare organisms are extremely difficult to isolate and identify.
Scientists at the University of Pennsylvania (Philadelphia, PA, USA) utilized a pathogen array technology referred to as PathoChip, comprised of oligonucleotide probes that can detect all the sequenced viruses as well as known pathogenic bacteria, fungi and parasites and family-specific conserved probes, thus providing a means for detecting previously uncharacterized members of a family. The technology contains 60,000 probes that simultaneously test for all known viruses, as well as a variety of bacteria, fungi, helminths, and protozoa.
The investigators applied the PathoChip test to tissue samples of a patient with relapsed acute myelogenous leukemia (AML). The patient, a middle-aged man, had undergone chemotherapy for the cancer, a treatment that is well known to weaken the immune system, increasing susceptibility to infection. As a result, he developed an unknown fungal infection. The team rapidly identified a zygomycetous fungus, Rhizomucor, an otherwise challenge for the clinical laboratories, predominantly in the patient with acute myelogenous leukemia.
Erle Robertson, PhD, a professor and vice-chair for research in Otorhinolaryngology, said, “We've run many tests to see if we could identify pathogens in the laboratory, just to see if the PathoChip has efficacy in identifying a variety of organisms, and we were able to identify all infectious agents tested, but this was the first time we actually looked directly at a patient sample to identify a pathogenic agent. With this technology, out of 60,000 possibilities and probes that we used, in a little over 24 hours we were able to identify this particular fungi.” The study was published originally online on November 20, 2015, in the journal Cancer, Biology & Therapy.
Related Links:
University of Pennsylvania
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data